A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

Clinical trial NCT06322667 · RECRUITING

Trial details

NCT number: NCT06322667
Sponsor: Eisai Co., Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Alzheimer's Disease

Start date: 2024-02-14
Primary completion: 2027-12-31
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.